Back
Church & Dwight 10K Form
Sell
34
CHD
Church & Dwight
Last Price:
$106.16
Seasonality Move:
4.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-03 | 10Q | CHD/Church & Dwight Quarterly |
2023-07-28 | 10Q | CHD/Church & Dwight Quarterly |
2023-04-27 | 10Q | CHD/Church & Dwight Quarterly |
2022-10-28 | 10Q | CHD/Church & Dwight Quarterly |
2022-07-29 | 10Q | CHD/Church & Dwight Quarterly |
2022-04-28 | 10Q | CHD/Church & Dwight Quarterly |
Receive CHD News And Ratings
See the #1 stock for the next 7 days that we like better than CHD
CHD Financial Statistics
Sales & Book Value
Annual Sales: | $5.9B |
---|---|
Cash Flow: | $315.4M |
Price / Cash Flow: | 29.95 |
Annual Sales: | $17.12 |
Price / Book: | 6.2 |
Profitability
EPS (TTM): | 2.23000 |
---|---|
Net Income (TTM): | $549.8M |
Gross Margin: | $2.6B |
Return on Equity: | 13.41% |
Return on Assets: | 6.35% |
Church & Dwight Earnings Forecast
Key Church & Dwight Financial Ratios
-
The Gross Profit Margin over the past 40 years for CHD is 44.11%.
-
The Selling, General & Administrative Expenses for CHD have been equal to 26.09% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 14.68% of Operating Income.
-
The Net Earning history of CHD is 12.88% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 31 years.
Church & Dwight Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Household Products |
Sector: | Consumer Staples |
Current Symbol: | CHD |
CUSIP: | 171340 |
Website: | churchdwight.com |
Debt
Debt-to-Equity Ratio: | 0.53 |
---|---|
Current Ratio: | 1.62 |
Quick Ratio: | 1.05 |
Price-to-Earnings
Trailing P/E Ratio: | 34.79 |
---|---|
Forward P/E Ratio: | 28.45 |
CHD Technical Analysis vs Fundamental Analysis
Sell
34
Church & Dwight (CHD)
is a Sell
Is Church & Dwight a Buy or a Sell?
-
Church & Dwight stock is rated a SellThe current Church & Dwight [CHD] share price is $106.10. The Score for CHD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.